The Ming Hsieh Institute for Research on Engineering-Medicine for Cancer (MHI) sponsors the Ming Hsieh Institute Research Award, which aims to make USC an international leader in translational research that bridges basic science, engineering, computing, and medicine. The MHI was established in 2010 through a generous gift from Ming Hsieh, a graduate of the USC Viterbi School of Engineering, founder of Cogent Systems and Fulgent Genetics, USC Trustee, and a member of the National Academy of Engineering and the National Academy of Inventors. The MHI’s main goal is to support integrated interdisciplinary translational research that speeds discovery and creates pathways to rapidly improve the lives of cancer patients. Its commitment to supporting new and creative approaches and breakthrough interdisciplinary ideas drives advances in engineering, computing, and science into treatments and cures for cancer. The Ming Hsieh Institute Research Award (MHIRA) aims to promote the integration of engineering, scientific and medical research that together generates novel thinking and the interdisciplinary and collaborative research needed to speed discovery and be translated into real improvements in human health.
|Deadline: 5 PM, January 29, Annually
View the RFP for full proposal requirements.
Previous awardees can be found at Ming Hsieh Institute for Research on Engineering-Medicine for Cancer.